115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): A multicentre, open-label, phase 2 study
    Journal Article

    Strickler, J. H.; Cercek, A.; Siena, S.; AndreĢ, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J. M.; Coveler, A. L.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • On the need for landmark analysis or time-dependent covariates
    Editorial

    Zabor, E. C.; Assel, M.
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Letter to the editor: Reply to Zhao, Wu, and Ma
    Correspondence

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Schoenfeld, A. J.; Awad, M. M.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA/SUO Guideline
    Guidelines

    Coleman, J. A.; Clark, P. E.; Bixler, B. R.; Buckley, D. I.; Chang, S. S.; Chou, R.; Hoffman-Censits, J.; Kulkarni, G. S.; Matin, S. F.; Pierorazio, P. M.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors
    Journal Article

    Ma, S.; Patell, R.; Miller, E.; Ren, S.; Marquez-Garcia, J.; Panoff, S.; Sharma, R.; Pinson, A.; Elavalakanar, P.; Weber, G.; more...
    Journal of Thrombosis and Haemostasis (2023)

    Fulltext@MSK | Save
  • Cost-effectiveness analyses in AML: What have we learned, how should this impact patient care, and what needs to be done in the future?
    Review

    Bewersdorf, J. P.; Huntington, S. F.; Zeidan, A. M.
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Incorporating health equity in the neurology curriculum: Our experience
    Journal Article

    Kaplan, T. B.; Doughty, C.; Nolen, L.; Budhu, J.
    Journal of the Neurological Sciences (2023)

    Fulltext@MSK | Save
  • Acute myeloid leukemia, version 3.2023: NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Pollyea, D. A.; Altman, J. K.; Assi, R.; Bixby, D.; Fathi, A. T.; Foran, J. M.; Gojo, I.; Hall, A. C.; Jonas, B. A.; Kishtagari, A.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • NCCN GuidelinesĀ® Insights: Distress management, version 2.2023
    Guidelines

    Riba, M. B.; Donovan, K. A.; Ahmed, K.; Andersen, B.; Braun, I.; Breitbart, W. S.; Brewer, B. W.; Corbett, C.; Fann, J.; Fleishman, S.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Imaging modalities for measuring body composition in patients with cancer: Opportunities and challenges
    Review

    Shah, U. A.; Ballinger, T. J.; Bhandari, R.; Dieli-Cornwright, C. M.; Guertin, K. A.; Hibler, E. A.; Kalam, F.; Lohmann, A. E.; Ippolito, J. E.
    Journal of the National Cancer Institute - Monographs (2023)

    Fulltext@MSK | Save